Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop.
Essentials The clinical enumeration of microparticles (MPs) is hampered by a lack of standardization. A new strategy to standardize MP counts by flow cytometry was evaluated in a multicenter study. No difference was found between instruments using forward or side scatter as the trigger parameter. This study demonstrated that beads can be used as a standardization tool for MPs. Click to hear the ISTH Academy's webinar on microvesicles SUMMARY: Background Microparticles (MPs) are extracellular vesicles resulting from the budding of cellular membranes that have a high potential as emergent biomarkers; however, their clinical relevance is hampered by methodological enumeration concerns and a lack of standardization. Flow cytometry (FCM) remains the most commonly used technique with the best capability to determine the cellular origin of single MPs. However, instruments behave variably depending on which scatter parameter (forward (FSC) or side scatter (SSC)) provides the best resolution to discriminate submicron particles. To overcome this problem, a new approach, based on two sets of selected beads adapted to FSC or SSC-optimized instruments, was recently proposed to reproducibly enumerate platelet-derived MP counts among instruments with different optical systems. Objective The objective was to evaluate this strategy in an international workshop that included 44 laboratories accounting for 52 cytometers of 14 types. Methods/Results Using resolution capability and background noise level as criteria to qualify the instruments, the standardization strategy proved to be compatible with 85% (44/52) of instruments. All instruments correctly ranked the platelet MP (PMP) levels of two platelet-free plasma samples. The inter-laboratory variability of PMP counts was 37% and 28% for each sample. No difference was found between instruments using forward or side-scattered light as the relative sizing parameter. Conclusions Despite remaining limitations, this study is the first to demonstrate a real potential of bead-based strategies for standardization of MP enumeration across different FCM platforms. Additional standardization efforts are still mandatory to evaluate MPs' clinical relevance at a multicenter level.
VRCM, UMR-S1076, Aix-Marseille Université, INSERM, UFR de Pharmacie, Marseille, France.|Hematology and Vascular Biology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
S
S
Cointe
Hematology and Vascular Biology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.|R and T Department, BioCytex, Marseille, France.
C
C
Judicone
VRCM, UMR-S1076, Aix-Marseille Université, INSERM, UFR de Pharmacie, Marseille, France.
S
S
Robert
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
M J
MJ
Mooberry
R and T Department, BioCytex, Marseille, France.
P
P
Poncelet
Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
M
M
Wauben
Laboratory of Experimental Clinical Chemistry, Academic Medical Center, Amsterdam, the Netherlands.
R
R
Nieuwland
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
N S
NS
Key
VRCM, UMR-S1076, Aix-Marseille Université, INSERM, UFR de Pharmacie, Marseille, France.|Hematology and Vascular Biology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
F
F
Dignat-George
VRCM, UMR-S1076, Aix-Marseille Université, INSERM, UFR de Pharmacie, Marseille, France.|Hematology and Vascular Biology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
R
R
Lacroix
D002138:Calibration; D055252:Cell-Derived Microparticles; D005434:Flow Cytometry / Q000592:standards*; D006801:Humans; D009504:Neutrophils / Q000378:metabolism; D010316:Particle Size; D010949:Plasma; D010976:Platelet Count; D012680:Sensitivity and Specificity
cell-derived microparticles; extracellular vesicles; flow cytometry; multicenter study; standardization
Curr Protoc Cytom. 2015 Jul 01;73:13.14.1-16
26132176
J Thromb Haemost. 2013 Apr 2;:null
23551930
J Biomed Opt. 2012 May;17(5):057006
22612145
J Extracell Vesicles. 2014 Nov 24;3:25361
25425324
J Thromb Haemost. 2011 Aug;9(8):1676-8; author reply 1681-2
21645234
Cytometry A. 2016 Feb;89(2):196-206
26484737
Cytometry A. 2016 Feb;89(2):184-95
25857288
ACS Nano. 2014 Oct 28;8(10):10998-1006
25300001
Cytometry A. 2016 Feb;89(2):148-58
25963580
J Thromb Haemost. 2014 Jul;12(7):1182-92
24818656
J Thromb Haemost. 2011 Aug;9(8):1679-81; author reply 1681-2
21645233
J Thromb Haemost. 2015 Feb;13(2):237-47
25348269
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):1054-8
22328775
Curr Protoc Cytom. 2007 Apr;Chapter 1:Unit1.21
18770847
Nat Protoc. 2012 Jun 14;7(7):1311-26
22722367
Clin Ther. 2014 Jun 1;36(6):830-46
24952934
J Thromb Haemost. 2010 Nov;8(11):2571-4
20831623
Nanomedicine. 2012 Jul;8(5):712-20
22024193
J Thromb Haemost. 2009 Jan;7(1):190-7
18983485
J Thromb Haemost. 2012 Mar;10(3):437-46
22212198